发明名称 |
METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER |
摘要 |
Provided herein are vaccine compositions having potent adjuvant activity. Such compositions are capable of increasing anti-gen-specific antibody responses and increased frequency of Her-2-specific CD4+ T-cells, have improved anti-tumor efficacy, and are useful in methods of treating cancer. |
申请公布号 |
US2015283220(A1) |
申请公布日期 |
2015.10.08 |
申请号 |
US201314435891 |
申请日期 |
2013.10.16 |
申请人 |
BAVARIAN NORDIC, INC. |
发明人 |
Mandl Stefanie;Rountree Ryan;Delcayre Alain |
分类号 |
A61K39/00;C12N15/86;C12N7/00 |
主分类号 |
A61K39/00 |
代理机构 |
|
代理人 |
|
主权项 |
1. A composition comprising a recombinant modified vaccinia virus Ankara (“MVA”) expressing a polypeptide comprising a heterologous tumor-associated antigen and a recombinant protein comprising the heterologous tumor-associated antigen. |
地址 |
Mountain View, CA US |